Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure (Q44633040)

4 December 2017

title

Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure (English)

1 reference

4 December 2017

main subject

chronic heart failure

1 reference

Anna Vasků

1

1 reference

4 December 2017

Monika Goldbergová

2

1 reference

4 December 2017

Lydie Izakovicová Hollá

3

1 reference

4 December 2017

Lenka Spinarová

4

1 reference

4 December 2017

Jindrich Spinar

5

1 reference

4 December 2017

Jirí Vítovec

6

1 reference

4 December 2017

Jirí Vácha

7

1 reference

4 December 2017

publication date

1 October 2003

1 reference

Clinical Chemistry and Laboratory Medicine

4 December 2017

published in

1 reference

4 December 2017

volume

41

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1299-1303

1 reference

Extracellular degradative pathways in myocardial remodeling and progression to heart failure

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

[Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Strategies to achieve coronary arterial plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Matrix metalloproteinases: a therapeutic target in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.197

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.197

1 reference

4 December 2017

1 reference